Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Orion Oyj

Market Cap 9.47B 10.84B 8.76B 8.18B 15.35B 1,025B 15.47B 104B 40.52B 504B 40.7B 39.82B 1,750B P/E 2026 *
17.2x
P/E 2027 * 14.6x
Enterprise Value 9.37B 10.73B 8.67B 8.09B 15.19B 1,014B 15.3B 103B 40.08B 498B 40.27B 39.4B 1,731B EV / Sales 2026 *
4.5x
EV / Sales 2027 * 3.9x
Free-Float
90.5%
Yield 2026 *
2.83%
Yield 2027 * 3.14%
1 day+1.56%
1 week+0.22%
Current month-4.33%
1 month-4.13%
3 months-0.58%
6 months+10.13%
Current year+7.62%
1 week 66.1
Extreme 66.1
68.75
1 month 66.1
Extreme 66.1
72.5
Current year 62.7
Extreme 62.7
75.3
1 year 56.5
Extreme 56.5
75.3
3 years 31.86
Extreme 31.86
75.3
5 years 31.86
Extreme 31.86
75.3
10 years 22.57
Extreme 22.57
75.3
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Date Insider Type Main position Quantity % Market Cap.
08/08/25Sell

Chief Operating Officer

4,000 0.0122%
04/08/25Sell

Executive/Senior Manager

71 0.0002%
04/08/25Sell

Executive/Senior Manager

605 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%+0.22%+7.54%+78.99% 10.87B
+0.38%-2.08%+43.51%+141.63% 980B
+1.17%-2.05%+52.54%+39.37% 550B
+5.61%+3.77%+25.13%+67.34% 382B
-0.06%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+3.59%-1.73%+26.43%+49.98% 182B
+2.21%+0.35%+17.46%+59.69% 154B
Average +1.64%-2.47%+21.36%+45.62% 331.32B
Weighted average by Cap. +1.47%-3.36%+31.23%+64.71%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.8B 3.37B 225B 3.4B 22.87B 8.9B 111B 8.94B 8.75B 384B 2.35B 2.69B 2.18B 2.03B 3.81B 254B 3.84B 25.85B 10.06B 125B 10.1B 9.88B 434B
Net income 550M 629M 508M 474M 891M 59.43B 897M 6.04B 2.35B 29.22B 2.36B 2.31B 102B 649M 743M 600M 560M 1.05B 70.21B 1.06B 7.14B 2.78B 34.52B 2.79B 2.73B 120B
Net Debt -101M -115M -93.1M -86.9M -163M -10.89B -164M -1.11B -430M -5.35B -432M -423M -18.59B -313M -358M -289M -270M -507M -33.82B -511M -3.44B -1.34B -16.63B -1.34B -1.31B -57.77B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,132
Date Price Change Volume
23/06/26 68.50 +1.71% 372,530
18/06/26 67.35 -1.25% 1,014,791
17/06/26 68.20 +1.49% 256,281
16/06/26 67.20 +0.90% 211,991
15/06/26 66.60 -2.56% 178,885
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
68.50EUR
Average target price
74.33EUR
Spread / Average Target
+8.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ORNBV Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!